Jerry Li

A comparative evaluation of Bayesian model-assisted two-stage designs for Phase I/II clinical trials.

The primary goal of a two-stage Phase I/II trial is to identify the optimal dose for the following large-scale Phase III trial. Conventional Phase I designs focus on the maximum tolerated dose (MTD), assuming that efficacy increases monotonically with dose. However, this assumption may not hold for novel therapies such...